Hormonal Contraceptive Market to Accrue Remarkable Proceeds via Upsurge of Health & Fitness Centers by 2023


Posted June 3, 2019 by mangeshpanhale

A new market study, titled “Global Hormonal Contraceptive Market Analysis, Forecast to 2023”, has been featured on Allied Market Research
 
The Global Hormonal Contraceptive Market accounted for $13,924 million in 2016, and is estimated to reach $16,018 million by 2023, registering a CAGR of 1.9% from 2017 to 2023. North America is the highest contributor in the hormonal contraceptive market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

Hormonal contraception acts on the endocrine system to prevent unwanted pregnancy. Synthetic forms of naturally occurring hormones such as progestin and estrogen are used to prevent ovulation and avoid fertilization. These forms of birth control methods also change the environment of the uterus, making it unfavorable for fertilization. Hormonal contraceptives are available in a variety of forms such as patches, pill, injection, and rings, which are safe and reliable forms of hormonal contraceptives to prevent pregnancy.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4574

The major driving factors of the hormonal contraceptive market are increase in focus towards family planning, health issues associated with teenage pregnancies, increase in awareness about modern contraception methods, and rise in use of oral pills as a key method to prevent unplanned pregnancy. The advancement in hormonal contraception with better efficacy and fewer side effects further boost the market growth. However, availability of alternate contraceptive methods, health risks associated with the use of contraceptives, and lack of social acceptance adversely affect the market growth.

The Major key players Are:

• Female Health Company
• Teva Pharmaceutical Industries Limited
• Bayer AG
• Pfizer, Inc.
• Mylan N.V.
• Johnson & Johnson
• Ansell LTD.
• Mayer Laboratories
• Merck & Co., Inc.
• Church & Dwight, Co., Inc.

Get a purchase enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/4574

The Other Key players Are:

• Reckitt Benckiser Plc.
• Warner Chilcott Company
• BioSante Pharmaceuticals Inc.
• HLL Lifecare Limited
• Boehringer Ingelheim GmbH
• Watson Pharmaceuticals, Inc.
• V-Care Pharma Pvt. Ltd.
• Vardhman Life Care Pvt. Ltd.
• Cipla Limited
• Others.

Among the product, oral contraceptive pill is the dominant segment, as these pills are easily available and have high success rate of up to 99% to prevent pregnancy. However, vaginal ring register the highest growth rate, due to the ease of usage and fewer side effects caused by it.

Access Full report @ https://www.alliedmarketresearch.com/hormonal-contraceptive-market

Combined hormonal contraceptive is the dominant segment in the hormonal contraceptive market, due to the wide availability of combined hormonal contraceptive along with better efficiency to prevent pregnancy.
In 2016, North America was the major revenue generator, owing to increase in awareness towards the benefits of using hormonal contraceptive, high prevalence of unwanted pregnancy, and favorable regulatory scenario. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, due to presence of populace countries such as India and China where there is greater need to control the growing population.

Key Findings of the Hormonal Contraceptive Market:

• Vaginal rings is projected to grow at the highest rate during the analysis period.
• North America dominated global hormonal contraceptive market in 2016, and is projected to continue its dominance in future.
• China is expected to grow at the highest rate in the Asia-Pacific region during the forecast period.
• Hospitals is the largest contributor among the end user segments in 2016.
• The 15-24 years age group segment generated the highest revenue, and is expected to continue its dominance in future.

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
[email protected]
Web: www.alliedmarketresearch.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Allied Market Research
Phone +1-800-792-5285
Business Address 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States
Country United States
Categories Health
Tags hormonal contraceptive industry , hormonal contraceptive market share , hormonal contraceptive market size
Last Updated June 3, 2019